Interleukin-17 family and IL-17 receptors

被引:864
作者
Moseley, TA [1 ]
Haudenschild, DR [1 ]
Rose, L [1 ]
Reddi, AH [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA
关键词
interleukin-17; T-cells; receptors; prostate; cartilage; cancer;
D O I
10.1016/S1359-6101(03)00002-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-17 (IL-17) is a pro-inflammatory cytokine secreted by activated T-cells. Recently discovered related molecules are forming a family of cytokines, the IL-17 family. The prototype member of the family has been designated IL-17A. Due to recent advances in the human genome sequencing and proteomics five additional members have been identified and cloned: IL-17B, IL-17C, IL-17D, IL-17E and IL-17F. The cognate receptors for the IL-17 family identified thus far are: IL-17R, IL-17RH1, IL-17RL (receptor like), IL-17RD and IL-17RE. However, the ligand specificities of many of these receptors have not been established. The IL-17 signaling system is operative in disparate tissues such as articular cartilage, bone, meniscus, brain, hematopoietic tissue, kidney, lung, skin and intestine. Thus, the evolving IL-17 family of ligands and receptors may play an important role in the homeostasis of tissues in health and disease beyond the immune system. This survey reviews the biological actions of IL-17 signaling in cancers, musculoskeletal tissues, the immune system and other tissues. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:155 / 174
页数:20
相关论文
共 116 条
[1]  
Albanesi C, 1999, J IMMUNOL, V162, P494
[2]   Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17 plus tumor necrosis factor-α-induced stabilization of interleukin-6 mRNA in human pancreatic myofibroblasts [J].
Andoh, A ;
Shimada, M ;
Bamba, S ;
Okuno, T ;
Araki, Y ;
Fujiyama, Y ;
Bamba, T .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1591 (1-3) :69-74
[3]   Cooperation of interleukin-17 and interferon-γ on chemokine secretion in human fetal intestinal epithelial cells [J].
Andoh, A ;
Takaya, H ;
Makino, J ;
Sato, H ;
Bamba, S ;
Araki, Y ;
Hata, K ;
Shimada, M ;
Okuno, T ;
Fujiyama, Y ;
Bamba, T .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (01) :56-63
[4]  
Antonysamy MA, 1999, J IMMUNOL, V162, P577
[5]   Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival [J].
Antonysamy, MA ;
Fanslow, WC ;
Fu, F ;
Li, W ;
Qian, S ;
Troutt, AB ;
Thomson, AW .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :93-93
[6]   Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage [J].
Attur, MG ;
Patel, RN ;
Abramson, SB ;
Amin, AR .
ARTHRITIS AND RHEUMATISM, 1997, 40 (06) :1050-1053
[7]  
Awane M, 1999, J IMMUNOL, V162, P5337
[8]   Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism [J].
Benchetrit, F ;
Ciree, A ;
Vives, V ;
Warnier, G ;
Gey, A ;
Sautès-Fridman, C ;
Fossiez, F ;
Haicheur, N ;
Fridman, WH ;
Tartour, E .
BLOOD, 2002, 99 (06) :2114-2121
[9]   Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? [J].
Broxmeyer, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2411-2415
[10]   Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein [J].
Bush, KA ;
Farmer, KA ;
Walker, JS ;
Kirkham, BW .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :802-805